. ADH amplified ethanol-induced reactive oxygen species generation, which was nullified by the CAT transgene. Western blot analysis showed that ethanol reduced ERK phosphorylation and enhanced JNK phosphorylation without affecting p38 phosphorylation. The ethanol-induced changes in phosphorylation of ERK and JNK were amplified by ADH. CAT transgene itself did not affect ethanol-induced response in ERK and JNK phosphorylation, but it cancelled ADH-induced effects. These data suggest that antioxidant CAT may effectively antagonize ADH-induced enhanced cardiac depression in response to ethanol. myocyte; shortening; intracellular Ca 2ϩ transient ALCOHOLISM LEADS TO heart muscle damage, namely alcoholic cardiomyopathy, and increased cardiac mortality (8, 31). Alcoholic cardiomyopathy is usually featured by cardiac hypertrophy, disrupted myocardial ultrastructure, decreased ejection fraction, reduced myocardial contractility, and elevated risk of stroke and hypertension (19, 31) . Several theories have been speculated to be responsible for pathogenesis of alcoholic cardiomyopathy, including toxicity of alcohol, its metabolite acetaldehyde and fatty acid ethyl esters, as well as accumulation of reactive oxygen species (ROS) and/or reduced antioxidant defense (20, 24, 31) , suggesting a likelihood role of the alcohol metabolite acetaldehyde and oxidative stress in alcohol-initiated heart diseases in populations with chronic alcohol consumption. This is supported with the notion that free radical generation and oxidative stress following alcohol ingestion appear to be essential to the toxicity of ethanol and acetaldehyde (10, 31). Ethanol-induced accumulation of free radicals and oxidative stress is directly associated with its metabolic pathways, including alcohol dehydrogenase (ADH), microsomal ethanol oxidation system, and catalase, which may produce superoxide anion 1-hydroxyethyl radical and lessen the enzymatic/nonenzymatic antioxidant defense systems (10, 31). However, exactly how ethanol produces cytotoxicity and mediates cardiomyopathy through its metabolic intermediate(s) remains poorly understood. The "acetaldehyde toxicity" theory of alcohol cardiomyopathy received convincing support from our laboratories recent studies using a transgenic mouse model of cardiac-specific overexpression of ADH (6, 7, 12) . Through elevated cardiac expression of ADH, the enzyme that hydrolyzes ethanol into acetaldehyde, the progression and severity of cardiomyopathy following alcohol consumption or ethanol exposure become significantly "accelerated" both functionally and morphologically (6, 7, 12, 15) . This accelerated alcoholic cardiomyopathy is apparently associated with enhanced cardiac acetaldehyde levels (7, 12) and seems to be consistent with the observation that acetaldehyde directly impairs cardiac excitation-contraction coupling and inhibits sarco(endo)plasmic reticulum Ca 2ϩ release function (1, 21, 22) . Nevertheless, the mechanism through which facilitated alcoholic myopathic alteration develops has not been fully unveiled. The aim of this study was to investigate the impact of the antioxidant catalase (CAT) on ADH-induced amplification of ethanol-elicited depression of cardiac function to examine the role of antioxidant defense in ADH-induced accelerated cardiomyopathy. We generated a novel double transgenic model with cardiac-specific overexpression of both ADH and CAT genes. Myocyte shortening, intracellular Ca 2ϩ homeostasis, and mitogen-activated protein (MAP) kinase stress signals including extracellular signalregulated kinase (ERK), c-Jun NH 2 -terminal kinase (JNK) and p38 MAP kinase following acute ethanol exposure were evaluated in hearts from wild-type FVB, catalase, ADH, and ADH-CAT double transgenic mice. Activation of ERK, JNK, and p38 MAP kinases is essential in the onset of morphological and mechanical dysfunctions of the hearts with characteristic gene expression alteration including elevated transcription of atrial natriuretic factor, ␤-myosin heavy chain (MHC), ␣-skel-
properties. ADH or ADH-CAT myocytes had higher acetaldehydeproducing ability. Ethanol (80 -640 mg/dl) suppressed FVB cell shortening and intracellular Ca 2ϩ transients with maximal inhibitions of 43.5 and 45.2%, respectively. Ethanol-induced depression on cell shortening and intracellular Ca 2ϩ was augmented in ADH group with maximal inhibitions of 66.8 and 69.6%, respectively. Interestingly, myocytes from CAT-ADH mice displayed normal ethanol response with maximal inhibitions of 46.0 and 47.2% for cell shortening and intracellular Ca 2ϩ , respectively. CAT transgene lessened ethanolinduced inhibition on cell shortening (maximal inhibition of 30.3%) but not intracellular Ca 2ϩ . ADH amplified ethanol-induced reactive oxygen species generation, which was nullified by the CAT transgene. Western blot analysis showed that ethanol reduced ERK phosphorylation and enhanced JNK phosphorylation without affecting p38 phosphorylation. The ethanol-induced changes in phosphorylation of ERK and JNK were amplified by ADH. CAT transgene itself did not affect ethanol-induced response in ERK and JNK phosphorylation, but it cancelled ADH-induced effects. These data suggest that antioxidant CAT may effectively antagonize ADH-induced enhanced cardiac depression in response to ethanol. myocyte; shortening; intracellular Ca 2ϩ transient ALCOHOLISM LEADS TO heart muscle damage, namely alcoholic cardiomyopathy, and increased cardiac mortality (8, 31) . Alcoholic cardiomyopathy is usually featured by cardiac hypertrophy, disrupted myocardial ultrastructure, decreased ejection fraction, reduced myocardial contractility, and elevated risk of stroke and hypertension (19, 31) . Several theories have been speculated to be responsible for pathogenesis of alcoholic cardiomyopathy, including toxicity of alcohol, its metabolite acetaldehyde and fatty acid ethyl esters, as well as accumulation of reactive oxygen species (ROS) and/or reduced antioxidant defense (20, 24, 31) , suggesting a likelihood role of the alcohol metabolite acetaldehyde and oxidative stress in alcohol-initiated heart diseases in populations with chronic alcohol consumption. This is supported with the notion that free radical generation and oxidative stress following alcohol ingestion appear to be essential to the toxicity of ethanol and acetaldehyde (10, 31) . Ethanol-induced accumulation of free radicals and oxidative stress is directly associated with its metabolic pathways, including alcohol dehydrogenase (ADH), microsomal ethanol oxidation system, and catalase, which may produce superoxide anion 1-hydroxyethyl radical and lessen the enzymatic/nonenzymatic antioxidant defense systems (10, 31) . However, exactly how ethanol produces cytotoxicity and mediates cardiomyopathy through its metabolic intermediate(s) remains poorly understood. The "acetaldehyde toxicity" theory of alcohol cardiomyopathy received convincing support from our laboratories recent studies using a transgenic mouse model of cardiac-specific overexpression of ADH (6, 7, 12) . Through elevated cardiac expression of ADH, the enzyme that hydrolyzes ethanol into acetaldehyde, the progression and severity of cardiomyopathy following alcohol consumption or ethanol exposure become significantly "accelerated" both functionally and morphologically (6, 7, 12, 15) . This accelerated alcoholic cardiomyopathy is apparently associated with enhanced cardiac acetaldehyde levels (7, 12) and seems to be consistent with the observation that acetaldehyde directly impairs cardiac excitation-contraction coupling and inhibits sarco(endo)plasmic reticulum Ca 2ϩ release function (1, 21, 22) . Nevertheless, the mechanism through which facilitated alcoholic myopathic alteration develops has not been fully unveiled. The aim of this study was to investigate the impact of the antioxidant catalase (CAT) on ADH-induced amplification of ethanol-elicited depression of cardiac function to examine the role of antioxidant defense in ADH-induced accelerated cardiomyopathy. We generated a novel double transgenic model with cardiac-specific overexpression of both ADH and CAT genes. Myocyte shortening, intracellular Ca 2ϩ homeostasis, and mitogen-activated protein (MAP) kinase stress signals including extracellular signalregulated kinase (ERK), c-Jun NH 2 -terminal kinase (JNK) and p38 MAP kinase following acute ethanol exposure were evaluated in hearts from wild-type FVB, catalase, ADH, and ADH-CAT double transgenic mice. Activation of ERK, JNK, and p38 MAP kinases is essential in the onset of morphological and mechanical dysfunctions of the hearts with characteristic gene expression alteration including elevated transcription of atrial natriuretic factor, ␤-myosin heavy chain (MHC), ␣-skel-etal actin, integrins and tubulin, and reduced expression of phospholamban and sarco(endo)plasmic reticulum Ca 2ϩ -ATPase. It has been demonstrated that ethanol, acetaldehyde, and other reactive aldehydes are important inducers of the MAP kinase signaling cascade, which play critical roles in the progression of alcoholic cardiomyopathy (3, 28, 31) .
MATERIALS AND METHODS

Generation and identification of cardiac ADH-CAT double transgenic mice.
All animal procedures were approved by the Animal Care and Use Committees at the University of North Dakota (Grand Forks, ND) and the University of Wyoming (Laramie, WY). Briefly, either ADH or CAT transgene was constructed to produce transgenic mice with cardiac-specific overexpression of either ADH or CAT as characterized earlier (7, 13, 15, 30) . Mouse ␣-MHC promoter was used to drive cardiac-specific expression. cDNA for either murine class I ADH, which converts ethanol to acetaldehyde, or rat catalase, which converts H 2O2 into O2 and H2O, was inserted behind the MHC promoter (13) . White albino FVB mice were used as the background (26) . For ADH line, a second transgene containing a cDNA for the enzyme tyrosinase was co-injected with ADH, resulting in coat color (light gray) pigmentation for identification of ADH-positive (ϳ40-fold increase in ADH expression) transgene (18) . On the other hand, identification of cardiac-specific CAT transgenic mice was performed using PCR technique as described previously (ϳ60-fold increase in CAT expression) (30) . A primer pair derived from MHC promoter and rat CAT cDNA was used with the reverse sequence of AAT ATC GTG GGT GAC CTC AA and the forward sequence of CAG ATG AAG CAG TGG AAG GA. The ADH-CAT double transgenic mice were generated by crossing ADH and CAT transgenic lines followed by PCR identification in light-gray colored offspring (ADH positive) (Fig. 1) . All mice were maintained with a 12:12-h light-dark cycle with free access to tap water and rodent chow. Male mice of ϳ4 mo of age were used for experimentation. For acute ethanol challenge experiment, mice were injected intraperitoneally with ethanol (3 g/kg body wt) and were killed 30 min later for cardiac tissue collection.
Cell isolation procedures. After ketamine/xylazine sedation, mouse hearts were removed and perfused with Krebs-Henseleit bicarbonate buffer containing (in mM) 118 NaCl, 4. (30) . Myocytes were used within 6 h of isolation.
Assessment of the acetaldehyde production after acute ethanol challenge. Isolated ventricular myocytes (200,000 cells/ml) from FVB, ADH, catalase, or ADH-CAT mice were exposed to 240 mg/dl ethanol for 15 min in a sealed vial before the reaction was terminated by 4-methylpyrazole (1 mM). Vials were then stored at Ϫ80°C until analysis. Immediately before analysis, the samples were warmed to 25°C. Two milliliters of the headspace gas from each vial was removed through the septum on the cap with a gas-tight syringe and transferred to a 200-l loop-injection system on a Hewlett-Packard 5890 gas chromatograph equipped with a flame ionization detector. Acetaldehyde and other components were separated on a 9-m VOCOL capillary column (Supelco) with a 1.8-m film thickness and an inner diameter of 0.32 mm. The temperature was held isothermally at 30°C, and the carrier gas was helium at a flow rate of 1.8 ml/min. Under these conditions, separation of acetaldehyde from ethanol and other compounds was complete in 1 min. Quantitation was achieved by calibrating the gas chromatography areas against those from headspace samples of known acetaldehyde standards over a similar concentration range as the cell samples in the same buffer (7) .
Cell shortening/relengthening. Mechanical properties of ventricular myocytes were assessed using an IonOptix MyoCam video-based edge-detection system (IonOptix, Milton, MA) as described previously (30) . In brief, cells were placed in a chamber mounted on the stage of an inverted microscope (Olympus IX-70) and superfused (ϳ2 ml/min at 25°C) with a buffer containing (in mM) 131 NaCl, 4 KCl, 1 CaCl 2, 1 MgCl2, 10 mM glucose, 10 HEPES, at pH 7.4. The cells were field stimulated to contract at a frequency of 0.5 Hz. Changes in cell length during shortening and relengthening were captured and converted to a digital signal. The myocyte being studied was rapidly scanned with a camera at 120 Hz to ensure recording with good fidelity. Cell shortening and relengthening were assessed using the following indexes: peak shortening, time to peak shortening (TPS) and time to 90% relengthening (TR90), and ϮdL/dt. Intracellular Ca 2ϩ fluorescence measurement. Myocytes were loaded with fura 2-AM (0.5 M) for 10 min at 25°C, and fluorescence measurements were recorded with a dual-excitation fluorescence photomultiplier system (Ionoptix) as previously described (30) . Myocytes were imaged through an Olympus IX-70 Fluor oil objective. Cells were exposed to light emitted by a 75-W lamp and passed through either a 360-or a 380-nm filter (bandwidths were Ϯ15 nm), while being stimulated to contract at 0.5 Hz. Fluorescence emissions were detected between 480 and 520 nm by a photomultiplier tube after first illuminating the cells at 360 nm for 0.5 s then at 380 nm for the duration of the recording protocol (333-Hz sampling rate). The 360 excitation scan was repeated at the end of the protocol, and qualitative changes in intracellular Ca 2ϩ concentration was inferred from the ratio of the fura 2 fluorescence intensity (FFI) at the two wavelengths. Fig. 1 . Identification of catalase-overexpressed transgenic mice. Genomic DNA was isolated from 2-cm tail clips from 1-mo-old mice. Catalase gene was identified by polymerase chain reaction using a primer pair derived from the myosin heavy chain (MHC) promoter and rat catalase cDNA. Intracellular fluorescence measurement of ROS. The membranepermeable probe 5-(6)-chloromethyl-2Ј,7Ј-dichlorodihydrofluorescein diacetate (Molecular Probes, Eugene, OR) enters the cells and produces a fluorescent signal after intracellular oxidation by ROS such as H 2O2. Intracellular ROS were monitored by changes in fluorescence intensity resulting from intracellular probe oxidation. After a 3-min acute ethanol (240 mg/dl) treatment, cardiac myocytes from FVB, ADH, CAT, and CAT-ADH mice were loaded with 10 M DCF for 30 min at 37°C before being washed with PBS buffer. Cells were sampled randomly using an Olympus BX-51 microscope equipped with an Olympus MagnaFire SP digital camera and ImagePro image analysis software (Media Cybernetics, Silver Spring, MD). Fluorescence was calibrated with InSpeck microspheres (Molecular Probes). More than 150 cells per data point were evaluated using the gridcrossing method for cell selection in Ͼ15 visual fields (5) .
Western blot analysis of ERK, pERK, JNK, p-JNK, p38, and pp38. The total protein was prepared as described previously (30) . In brief, left ventricles were rapidly removed and homogenized in a lysis buffer containing 20 mM Tris (pH 7.4), 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton, 0.1% SDS, and 1% protease inhibitor cocktail. Samples were then sonicated for 15 s and centrifuged at 12,000 g for 20 min at 4°C. The protein concentration of the supernatant was evaluated using the protein assay reagent (Bio-Rad, Hercules, CA). Equal-amount (50 g protein/lane) protein and prestained molecular weight marker (GIBCO, Gaithersburg, MD) were loaded onto 15% SDS-polyacrylamide gels in a minigel apparatus (Mini-PROTEAN II, Bio-Rad), separated, and transferred to nitrocellulose membranes (0.2-m pore size, Bio-Rad). Membranes were incubated for 1 h in a blocking solution containing 5% nonfat milk in TBS before being washed in TBS and incubated overnight at 4°C with anti-ERK (1:1,000), anti-phospho-ERK (pERK; 1:1,000), anti-JNK (1:1,000), anti-phospho-JNK (pJNK, 1:1,000), anti-p38 (1:1,000), and anti-phospho-p38 (pp38, 1:1,000) antibodies. Anti-ERK and antipERK antibody were purchased from Santa Cruz Biotechnology Fig. 2 . Acetaldehyde production in cardiomyocytes from FVB, alcohol dehydrogenase (ADH), catalse (CAT), or ADH-CAT mice. Cardiomyocytes were exposed to ethanol (240 mg/dl) for 15 min before levels of acetaldehyde were determined using gas chromatography. Values are means Ϯ SE; n ϭ 6 -7 mice per group. *P Ͻ 0.05 vs. FVB. Values are means Ϯ SE. PS, peak shortening; TPS, time to 90% PS; TR90, time to 90% relengthening; ϮdL/dt, maximal velocities of shortening and relengthening; ⌬360-to-380 ratio, peak 360-to-380 ratio Ϫ baseline 360-to-380 ratio; , fluorescence decay rate. *P Ͻ 0.05 vs. FVB and ADH groups.
(Santa Cruz, CA). All other antibodies were obtained from Cell Signaling Technology (Beverly, MA). After incubation with the primary antibodies, blots were incubated with either anti-mouse or anti-rabbit IgG horseradish peroxidase-linked antibodies at a dilution of 1:5,000 for 60 min at room temperature. Immunoreactive bands were detected using the Super Signal West Dura Extended Duration Substrate (Pierce, Milwaukee, WI). The intensity of bands was measured with a scanning densitometer (model GS-800; Bio-Rad) coupled with Bio-Rad personal computer analysis software.
Experimental protocols. For in vitro ethanol exposure, myocytes (fura 2 loaded or nonloaded) were first allowed to contract at a stimulation frequency of 0.5 Hz for 5 min to ensure steady state (myocytes with rundown Ͼ10% were not studied further) before perfusing with ethanol (80 -640 mg/dl) containing contractile buffer. A 3-min interval was allowed between the ethanol doses. Our previous experience indicated that ethanol-induced inhibition of cell shortening remains stable for up to 30 min (7, 23) . In ROS generation study, myocytes were loaded with 10 M dichlorofluorescein for 30 min at 37°C after the 3-min acute ethanol (240 mg/dl) exposure. For in vivo ethanol exposure, mice were injected intraperitoneally with ethanol (3 g/kg). Cardiac tissues were collected 30 min later for gel electrophoresis assessment.
Data analysis. Data were reported as means Ϯ SE. All data were statistically evaluated using a 2 ϫ 2 ANOVA design where one factor was transgene and the other ethanol concentration. Each index was assessed in separate ANOVAs. If the interaction term (transgene ϫ ethanol concentration) reached statistical significance (P Ͻ 0.05), then a Tukey's multiple comparison test was used to avoid inflated group ␣ effects and to identify which groups were statistically different. Table 1 , overexpression of ADH, catalase, or both did not elicit any notable effect on body, heart, liver, and kidney weights or organ size (when normalized to respective body weight) compared with those of the FVB wild-type littermates. Baseline mechanical and intracellular Ca 2ϩ properties of left-ventricular myocytes were essentially similar in left-ventricular myocytes from FVB, ADH, catalase, and ADH-CAT transgenic mice, with the only exception of significantly shorter resting myocyte length from the CAT mice ( Table 2 ), suggesting that the ADH or CAT transgenes themselves were unlikely innately harmful to intrinsic ventricular contractile function. The ability of ventricular myocytes to oxidize ethanol (240 mg/dl) into acetaldehyde measured by gas chromatography and flame ionization detection was significantly higher in myocytes from ADH and ADH-CAT groups compared with FVB and CAT groups (Fig. 2) , validating the identity of transgenic overexpression of ADH enzyme in both groups (increases ADH activity by ϳ40 times) (7, 15) . No difference was observed between ventricular myocytes from ADH and ADH-CAT double transgenic groups in their ability to convert ethanol into acetaldehyde (Fig. 2) . Acute effects of ethanol on cell shortening and intracellular Ca 2ϩ transients. To determine whether ADH and CAT transgenes affect ethanol-induced depression of cardiac myocyte shortening, concentration-dependent responses were constructed for ethanol (0 -640 mg/dl) in myocytes from FVB wild-type, ADH, catalase, and ADH-CAT mice. Acute exposure of ethanol did not affect the resting cell length (data not shown); however, it significantly depressed cell-shortening amplitude in all mouse groups. Consistent with our laboratory's previous reports (6, 7), ADH transgene significantly augmented the degree of ethanol-induced inhibition in cell shortening. The maximal inhibitions of myocyte shortening in response to ethanol were 43.5 and 66.8% in FVB and ADH groups, respectively. The threshold of ethanol-induced inhibition was reduced from 80 -120 mg/dl in FVB myocytes to Ͻ80 mg/dl in ADH myocytes. CAT transgene itself did not alter ethanol-induced inhibition of cell shortening (with a maximal inhibition of 30.3% and a threshold of inhibition between 80 and 120 mg/dl). Interestingly, CAT alleviated ADH transgeneaugmented suppression of cell shortening in response to ethanol exposure. The maximal inhibition of ethanol-induced cell shortening was 46.0% with a threshold between 80 and 120 mg/dl. The ethanol-induced inhibition of cell shortening in ADH myocytes was significantly greater than all other groups at doses of Ͼ80 mg/dl (Fig. 3A) . Acute ethanol exposure also prolonged duration of shortening (TPS) and relengthening (TR 90 ) and inhibited ϮdL/dt. Interestingly, ventricular myocytes from ADH mice were more sensitive to ethanol-induced effect on TPS, TR 90 , and ϮdL/dt with a much lower threshold of effectiveness (Table 3) . Consistent with its response on peak shortening, ethanol depressed the electrically stimulated rise in intracellular Ca 2ϩ FFI in a concentration-dependent manner (80 -640 mg/dl) in FVB myocytes, with a threshold between 80 and 120 mg/dl. CAT transgene did not affect the pattern of response for ethanol, whereas ADH transgene exacerbated ethanol-induced depression of FFI with a threshold of Ͻ80 mg/dl. Interestingly, CAT transgene nullified ADH transgeneelicited augmentation of ethanol-induced inhibition of FFI (Fig. 3B) . These results strongly indicated that the antioxidant CAT may abolish ADH transgene-amplified cardiac depression in response to acute ethanol exposure.
RESULTS
General features of FVB wild-type, ADH, catalase, and ADH-CAT transgenic mice and left ventricular myocytes from each group. As shown in
Acute effect of ethanol on ROS generation. Figure 4 reveals that a 3-min acute incubation of ethanol (240 mg/dl) with myocytes significantly increased intracellular ROS generation measured by 5-(6)-chloromethyl-2Ј,7Ј-dichlorodihydrofluorescein diacetate fluorescent intensity in all four myocyte groups tested. Interestingly, myocytes obtained from ADH mice dis- played significantly enhanced ROS accumulation in response to ethanol exposure compared with FVB group with ethanol exposure, suggesting that facilitation of acetaldehyde production may exacerbate ethanol-induced cellular toxicity. CAT effectively antagonized ethanol-induced ROS generation and was able to nullify ADH transgene-induced exacerbation in ROS generation in response to ethanol exposure. These data indicated that the antioxidant CAT may eliminate ADH transgene-amplified cardiac depression in response to acute ethanol exposure via a mechanism related to reduction in ROS generation.
Protein expression of stress-signaling molecules under acute ethanol exposure. Ethanol or its metabolite acetaldehyde has been demonstrated to exert its cytotoxic effect through one or more of the three distinct but parallel MAP kinase cascades, namely ERK, JNK, and p38 MAP kinase (31) . To examine possible involvement of these pathways, all four groups of mice (FVB, ADH, catalase, and ADH-catalase) were injected intraperitoneally with ethanol (3 g/kg) before cardiac tissues were collected 30 min later for gel electrophoresis. Our data revealed that total ERK or total JNK protein expression was not affected by ethanol treatment among all groups tested (including an ethanol-untreated FVB control group). However, phosphorylation of ERK and JNK was significantly reduced and enhanced, respectively, by ethanol treatment. The ethanolinduced response on phosphorylation of ERK and JNK was significantly amplified by the ADH transgene. Interestingly, the ADH transgene-elicited augmentation of ethanol response (depressed ERK phosphorylation and enhanced JNK phosphorylation) was blunted by the CAT transgene. CAT transgene itself did not affect pattern of ERK or JNK phosphorylation in response to ethanol. Although the extent of ethanol-induced reduction in ERK phosphorylation was significantly less in the CAT group compared with FVB group, the ratio of phosphorylated ERK to total ERK was similar between the two groups (Figs. 5 and 6 ). Finally, ethanol treatment did not affect the total and phosphorylated p38 MAP kinase. Neither ADH nor CAT transgene affected the nonresponse of ethanol on p38 MAP kinase expression and p38 MAP kinase phosphorylation (Fig. 7) .
DISCUSSION
The major finding of this study was that antioxidant CAT counteracts the ADH gene-elicited augmentation of ethanolinduced cardiac contractile depression, ROS generation, and alteration of stress signaling including ERK and JNK. Our laboratory's earlier study has indicated the significant role of acetaldehyde as an ultimate candidate toxin for alcoholic cardiomyopathy (6, 7, 12, 31) . Data from our present study revealed that cardiac-specific overexpression of ADH-amplified cardiac abnormalities (myocyte contraction and intracellular Ca 2ϩ handing) is likely due to enhanced acetaldehydemediated oxidative stress and/or reduction in antioxidant defense. Consistent with its effect on cell shortening, intracellular Ca 2ϩ transient, and ROS generation, ADH transgene sensitized myocardium to ethanol-induced response in stress signaling activation, which was also antagonized by the CAT transgene. These results suggested that the ADH enzyme may be a significant regulator in ethanol-induced cardiac depression by way of acetaldehyde production, alteration of redox state, and activation of stress signaling molecules.
As stated earlier, alcoholic cardiomyopathy usually displays cardiomegaly, disruptions of myofibrillary architecture, reduced myocardial contractility, and decreased ejection volume (19, 24) . Among all these cardiac anomalies, impaired contractile function and interrupted intracellular Ca 2ϩ handling are perhaps the most significant mechanisms leading to compromised myocardial function following ethanol exposure (4, 9, 27) . Evidence from our laboratory as well as others has indicated that the main metabolic product acetaldehyde plays a crucial role in disrupted intracellular Ca 2ϩ handling and cardiac excitation-contraction coupling (7, 17, 22, 31), consistent with the observation that enhanced cardiac acetaldehyde exposure is directly linked to exacerbated cardiac contractile dysfunction in ADH transgenic mice (12) . Acetaldehyde exerts a myogenic negative myocardial inotropic effect (1, 31) . Data from our present study revealed that ventricular myocytes from both ADH and ADH-CAT mice are capable of producing equally high levels of acetaldehyde from ethanol oxidization. However, the myocyte contraction and intracellular Ca 2ϩ transient properties were drastically different in these two groups, with myocytes from the ADH-CAT group showing a great degree of protection against acute ethanol-initiated insults. Because CAT is a potent antioxidant that elicits antioxidant protection against ethanol-induced cardiac contractile dysfunction (30) , it is natural to speculate that the catalase-elicited protection against ADH-augmented cardiac contraction dysfunction in response to ethanol is due to antioxidant defense from catalase. This is supported by the observation that alcohol intake directly contributes to reduction of the CAT enzymatic activity (11) . This notion received further support from our ERK and JNK phosphorylation study. ERK, JNK, and p38 MAP kinases have been shown to participate in acetaldehydeinduced cell toxicity (2, 25) , consistent with the concept that activation of MAP kinase family serves as a significant signaling mechanism for chronic alcohol ingestion-induced oxidative injury (29) . Acetaldehyde, as the highly reactive product from the oxidative metabolism of ethanol, is a critical mediator of ethanol-induced apoptosis via the activation of MAP kinase signaling pathway (14, 25) . This scenario should explain ADHinduced augmented response in ERK and JNK phosphorylation. The discrepant phosphorylation between ERK and JNK observed in our study may be due to pro-vs. anti-apoptotic properties of these two stress-signaling molecules. It is possible that acetaldehyde may selectively activate certain but not all family of the MAP kinase in different experimental settings. Further study is warranted to elucidate the stress signaling mechanisms involved in the ADH enzyme or acetaldehydeinduced cell toxicity.
In our present study, we found that ethanol (at 240 and 640 mg/dl) prolonged the duration of shortening (TPS) and relengthening (TR 90 ) in conjunction with depression of peak shortening, ϮdL/dt in myocytes from FVB mice. This is consistent with our laboratory's earlier study (7) . However, our recent study using both FVB and CAT mice revealed that ethanol (80 -640 mg/dl) prolonged relengthening duration but not that of shortening in myocytes from both FVB and CAT mice (30) . The rationale responsible for this apparent discrepancy in duration of cell shortening is unknown at this time. However, it may be speculated that subtle differences in the age and sex of FVB mice. Male FVB mice at the age of 4 mo were used in the present study compared with 5-mo-old mice of both genders used in an earlier study (30) . In addition, employment of a different batch of isolation enzyme (collagenase D) due to the availability from the vender may also contribute to viability of left ventricular myocytes. Other mechanisms not identified here may be also involved.
In summary, our present study provides evidence that antioxidant enzyme CAT may protect against ADH enzymeelicited augmentation of cardiac contractile and intracellular Ca 2ϩ dysfunction as well as ROS generation in response to ethanol exposure, supporting a role of oxidative stress in ADH-/acetaldehyde-associated myopathic alteration following ethanol exposure. Oxidant balance is crucial in maintaining normal cardiac contractile performance (10, 16) . However, the antioxidant reserves become inadequate under alcoholism such as CAT (11) . Future work with alcoholism and the assessment of cardiac contractile protein function using ADH and other antioxidant transgenic mice should provide in-depth knowledge for the precise nature of acetaldehyde and oxidative stress in the development of alcoholic cardiomyopathy.
